相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
Alessandra Vultaggio et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2020)
Update on eosinophilic granulomatosis with polyangiitis
Shunsuke Furuta et al.
ALLERGOLOGY INTERNATIONAL (2019)
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis
Jonathan Steinfeld et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature
Shogo Matsuda et al.
RHEUMATOLOGY INTERNATIONAL (2018)
Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review
Loic Raffray et al.
DRUGS (2018)
Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies
Erika P. Navarro-Mendoza et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report
G. Adami et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2018)
B cell therapy in ANCA-associated vasculitis: current and emerging treatment options (vol 14, pg 580, 2018)
Mark McClure et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases
Zeynep Celebi Sozener et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2018)
Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
Yann Nguyen et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies
Gizem Ayan et al.
RHEUMATOLOGY INTERNATIONAL (2018)
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Pierre Charles et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis
Emma E. van Daalen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity
Roser Solans-Laque et al.
MEDICINE (2017)
Case 32-2017: A 64-Year-Old Man with Dyspnea, Wheezing, Headache, Cough, and Night Sweats
Kerri Palamara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study
Patompong Ungprasert et al.
RHEUMATOLOGY (2017)
The 4 plus 2 rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
Dario Roccatello et al.
ONCOTARGET (2017)
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis
Jens Thiel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
Max Yates et al.
RMD OPEN (2017)
Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch-Schonlein purpura, ankylosing spondylitis, and Raynaud's phenomenon
Rbab Taha et al.
OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS (2017)
Sequential rituximab and omalizumab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
David Aguirre-Valencia et al.
CLINICAL RHEUMATOLOGY (2017)
Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study
Aikaterini Detoraki et al.
JOURNAL OF ASTHMA (2016)
COMPARISON OF RITUXIMAB WITH CYCLOPHOSPHAMIDE AS INDUCTION THERAPY IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS SYNDROME): A 24 MONTHS FOLLOW-UP ANALYSIS
N. Venhoff et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
Cindy Strehl et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
M. Yates et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
Christian Pagnoux et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Rituximab as induction therapy in relapsing eosinophilic granulomatosis with polyangiitis: A report of 6 cases
Pavel Novikov et al.
JOINT BONE SPINE (2016)
Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients
Marie Jachiet et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
A. J. Mohammad et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management
Matthieu Groh et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
First report of FIP1L1-PDGFRα-positive eosinophilic granulomatosis with polyangiitis
Giacomo Emmi et al.
RHEUMATOLOGY (2015)
Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence
Antonis Fanouriakis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Long-term safety and efficacy of rituximab in 7 Japanese patients with ANCA-associated vasculitis
Hiroko Nagafuchi et al.
MODERN RHEUMATOLOGY (2015)
Changing patterns of clinical severity and risk of mortality in granulomatosis with polyangiitis over four decades: the Russian experience
Pavel I. Novikov et al.
RHEUMATOLOGY INTERNATIONAL (2015)
Rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
Sebastian Andres Munoz et al.
REUMATOLOGIA CLINICA (2015)
EOSINOPHILIC GRANULOMATOSIS WITH POLIANGEITIS (EGPA): CLINICAL FEATURES AND OUTCOME IN A LARGE SERIE OF SPANISH PATIENTS
R. Solans-Laque et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
Luca Diamanti et al.
JOURNAL OF NEUROLOGY (2014)
Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG
Natsuka Umezawa et al.
MODERN RHEUMATOLOGY (2014)
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
L. Guillevin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients
Pierre Charles et al.
RHEUMATOLOGY (2014)
B cell depletion therapy and eosinophilic granulomatosis with polyangiitis with hepatic involvement
Antigoni Grigoriou et al.
RHEUMATOLOGY (2014)
Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany
Karen Herlyn et al.
RHEUMATOLOGY (2014)
Biological therapy for systemic vasculitis: A systematic review
Lucia Silva-Fernandez et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Classification of vasculitis: EMA classification using CHCC 2012 definitions
Rita Abdulkader et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort
Cloe Comarmond et al.
ARTHRITIS AND RHEUMATISM (2013)
A multicenter survey of rituximab for eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
A. Hot et al.
PRESSE MEDICALE (2013)
Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
Jens Thiel et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients
M. Wendt et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
Targeting Interleukin-5 in Refractory and Relapsing Churg-Strauss Syndrome
Frank Moosig et al.
ANNALS OF INTERNAL MEDICINE (2011)
Long-term follow-up of different refractory systemic vasculitides treated with rituximab
Frances Rees et al.
CLINICAL RHEUMATOLOGY (2011)
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement
Rodrigo Cartin-Ceba et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The Five-Factor Score Revisited Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort
Loic Guillevin et al.
MEDICINE (2011)
Difficult asthma and Churg-Strauss-like syndrome: A cautionary tale
Edmund M. T. Lau et al.
RESPIROLOGY (2011)
Churg-Strauss syndrome successfully treated with rituximab
Kristin Kveim Donvik et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Successful use of rituximab in a patient with Churg-Strauss syndrome and refractory central nervous system involvement
Jasemine Saech et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)
Alfonse T. Masi et al.
ARTHRITIS AND RHEUMATISM (2010)
Sustained response to mepolizumab in refractory Churg-Strauss syndrome
Jean-Emmanuel Kahn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
Sophia Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Severe bronchospasm associated with rituximab for refractory Churg-Strauss syndrome
M. -A Bouldouyre et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
EULAR recommendations for the management of primary small and medium vessel vasculitis
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Churg-Strauss Syndrome in Patients Treated With Omalizumab
Michael E. Wechsler et al.
CHEST (2009)
Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients
Svjetlana Lovric et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa
Aladdin J. Mohammad et al.
RHEUMATOLOGY (2009)
Treatment of Churg-Strauss syndrome without poor-prognosis factors
Camillo Ribi et al.
ARTHRITIS AND RHEUMATISM (2008)
A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases
Manuel Ramos-Casals et al.
MEDICINE (2008)
Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
R. J. Pepper et al.
RHEUMATOLOGY (2008)
Apparent response to anti-IgE therapy in two patients with refractory forme fruste'' of Churg-Strauss syndrome
S. Pabst et al.
THORAX (2008)
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
Bernhard Hellmich et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Administration of anti-IgE to a Churg-Strauss syndrome patient
Pedro Giavina-Bianchi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2007)
Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis - Remission, relapse, and re-treatment
K. G. C. Smith et al.
ARTHRITIS AND RHEUMATISM (2006)
Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome
RA Sinico et al.
ARTHRITIS AND RHEUMATISM (2005)
分享论文
